Terns Pharmaceuticals to Host Conference Call to Discuss

FOSTER CITY, Calif., June 13, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and…
Read More

Audited annual report 2020

On 11 June 2021, the Supervisory Council of AS Pro Kapital Grupp has approved the company’s 2020 audited annual report. Prior period errors When determining the fair value of investment property, double counting of assets or liabilities that are separately recognised in…
Read More

Audited annual report 2020

On 11 June 2021, the Supervisory Council of AS Pro Kapital Grupp has approved the company’s 2020 audited annual report. Prior period errors When determining the fair value of investment property, double counting of assets or liabilities that are separately recognised in…
Read More